Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701)

Phase Iii Trial ◽

Oncology Group Study ◽

Accelerated Fractionation ◽

Standard Fractionation

Accelerated Fractionation versus Conventional Fractionation Radiation Therapy for Glottic Cancer of T1-2N0M0 Phase III Study: Japan Clinical Oncology Group Study (JCOG 0701)

10.1093/jjco/hyn025 ◽

2008 ◽

Vol 38 (5) ◽

pp. 387-389 ◽

Cited By ~ 4

Author(s):

K. Nakamura ◽

T. Kodaira ◽

N. Shikama ◽

Y. Kagami ◽

S. Ishikura ◽

...

Keyword(s):

Radiation Therapy ◽

Clinical Oncology ◽

Phase Iii ◽

Glottic Cancer ◽

Oncology Group ◽

Oncology Group Study ◽

Conventional Fractionation ◽

Accelerated Fractionation ◽

Phase Iii Study

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

10.1093/jjco/hyy004 ◽

2018 ◽

Vol 48 (4) ◽

pp. 392-395 ◽

Cited By ~ 25

Author(s):

Kohei Nakachi ◽

Masaru Konishi ◽

Masafumi Ikeda ◽

Junki Mizusawa ◽

Junko Eba ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Tract Cancer

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin (TC) Versus Paclitaxel Plus Cisplatin (TP) in Stage IVB or Recurrent Cervical Cancer: Japan Clinical Oncology Group Study (JCOG0505)

Annals of Oncology ◽

10.1016/s0923-7534(20)32358-9 ◽

2012 ◽

Vol 23 ◽

pp. xi126 ◽

Cited By ~ 1

Author(s):

R. Kitagawa ◽

N. Katsumata ◽

T. Shibata ◽

T. Nakanishi ◽

S. Nishimura ◽

...

Keyword(s):

Cervical Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Recurrent Cervical Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Stage Ivb

A randomized controlled Phase III trial comparing 2-weekly docetaxel combined with cisplatin plus fluorouracil (2-weekly DCF) with cisplatin plus fluorouracil (CF) in patients with metastatic or recurrent esophageal cancer: rationale, design and methods of Japan Clinical Oncology Group study JCOG1314 (MIRACLE study)

10.1093/jjco/hyv012 ◽

2015 ◽

Vol 45 (5) ◽

pp. 494-498 ◽

Cited By ~ 12

Author(s):

K. Kataoka ◽

T. Tsushima ◽

J. Mizusawa ◽

S. Hironaka ◽

Y. Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Weekly Docetaxel ◽

Randomized Controlled ◽

Design And Methods

A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

10.1093/jjco/hyv178 ◽

2016 ◽

Vol 46 (2) ◽

pp. 174-177 ◽

Cited By ~ 32

Author(s):

Kozo Kataoka ◽

Hiroya Takeuchi ◽

Junki Mizusawa ◽

Masahiko Ando ◽

Yasuhiro Tsubosa ◽

...

Keyword(s):

Esophageal Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Thoracic Esophageal Cancer ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Open Esophagectomy

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON)

10.1093/jjco/hyx063 ◽

2017 ◽

Vol 47 (7) ◽

pp. 664-667 ◽

Cited By ~ 8

Author(s):

Kenjiro Namikawa ◽

Arata Tsutsumida ◽

Tomonori Mizutani ◽

Taro Shibata ◽

Tatsuya Takenouchi ◽

...

Keyword(s):

Adjuvant Therapy ◽

Clinical Oncology ◽

Cutaneous Melanoma ◽

Interferon Beta ◽

Stage Ii ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.4046 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4046-4046 ◽

Cited By ~ 21

Author(s):

Yoshiaki Iwasaki ◽

Masanori Terashima ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Kenichi Nakamura ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Large Type ◽

Type 3

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Annals of Oncology ◽

10.1093/annonc/mdq619 ◽

2011 ◽

Vol 22 (6) ◽

pp. 1382-1391 ◽

Cited By ~ 20

Author(s):

K. Ohmachi ◽

K. Tobinai ◽

Y. Kobayashi ◽

K. Itoh ◽

M. Nakata ◽

...

Keyword(s):

Clinical Oncology ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Phase III Trial of Upfront Debulking Surgery Versus Neoadjuvant Chemotherapy for Stage III/IV Ovarian, Tubal and Peritoneal Cancers: Japan Clinical Oncology Group Study JCOG0602

10.1093/jjco/hym145 ◽

2008 ◽

Vol 38 (1) ◽

pp. 74-77 ◽

Cited By ~ 37

Author(s):

T. Onda ◽

K. Matsumoto ◽

T. Shibata ◽

A. Sato ◽

H. Fukuda ◽

...

Keyword(s):

Neoadjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Debulking Surgery ◽

Phase Iii Trial ◽

Oncology Group Study

Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3)

10.1093/jjco/hyx108 ◽

2017 ◽

Vol 47 (10) ◽

pp. 986-990 ◽

Cited By ~ 5

Author(s):

Hidemichi Watari ◽

Hiroshi Katayama ◽

Taro Shibata ◽

Kimio Ushijima ◽

Toyomi Satoh ◽

...

Keyword(s):

Endometrial Cancer ◽

Clinical Oncology ◽

Pelvic Lymphadenectomy ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study